Natco Pharma launches Anastrazole tablets
Moneylife Digital Team 29 June 2010

Hyderabad-based Natco Pharma Ltd said it launched the generic version of Anastrazole 1 mg tablets in the US through the company’s marketing partners.

Anastrazole is used in the treatment of breast cancers and the market for this product in the US is expected to be in the region of $750 million per annum, according to a company press release on Tuesday.

On Tuesday, Natco Pharma shares fell 3.8% to Rs203 on the BSE, where the benchmark Sensex declined 1.4% to 17534 points.

Free Helpline
Legal Credit